Nanjing Vishee Valuation
| 688580 Stock | 34.52 1.91 5.24% |
At this time, the firm appears to be overvalued. Nanjing Vishee Medical secures a last-minute Real Value of USD27.95 per share. The latest price of the firm is USD34.52. Our model forecasts the value of Nanjing Vishee Medical from analyzing the firm fundamentals such as Return On Equity of 0.0618, current valuation of 2.28 B, and Profit Margin of 0.25 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.0506 | Enterprise Value 2.3 B | Enterprise Value Ebitda 18.4446 | Price Sales 8.2638 | Trailing PE 29.2542 |
Overvalued
Today
Please note that Nanjing Vishee's price fluctuation is not too volatile at this time. Calculation of the real value of Nanjing Vishee Medical is based on 3 months time horizon. Increasing Nanjing Vishee's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nanjing Vishee is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nanjing Stock. However, Nanjing Vishee's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 34.52 | Real 27.95 | Hype 34.83 | Naive 35.04 |
The real value of Nanjing Stock, also known as its intrinsic value, is the underlying worth of Nanjing Vishee Medical Company, which is reflected in its stock price. It is based on Nanjing Vishee's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nanjing Vishee's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nanjing Vishee Medical helps investors to forecast how Nanjing stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nanjing Vishee more accurately as focusing exclusively on Nanjing Vishee's fundamentals will not take into account other important factors: Nanjing Vishee Cash |
|
Nanjing Vishee Total Value Analysis
Nanjing Vishee Medical is presently forecasted to have takeover price of 2.28 B with market capitalization of 3.31 B, debt of 179.27 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Nanjing Vishee fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.28 B | 3.31 B | 179.27 M |
Nanjing Vishee Investor Information
About 70.0% of the company shares are owned by insiders or employees . The book value of Nanjing Vishee was presently reported as 16.97. The company last dividend was issued on the 5th of June 2024. Nanjing Vishee Medical had 1.4:1 split on the 5th of June 2024. Based on the measurements of operating efficiency obtained from Nanjing Vishee's historical financial statements, Nanjing Vishee Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 122.3 M | 154.3 M |
|
| |||||
| Operating Income | 113.7 M | 141.5 M |
|
|
Nanjing Vishee Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nanjing Vishee has an asset utilization ratio of 25.59 percent. This suggests that the Company is making USD0.26 for each dollar of assets. An increasing asset utilization means that Nanjing Vishee Medical is more efficient with each dollar of assets it utilizes for everyday operations.Nanjing Vishee Ownership Allocation
Nanjing Vishee Medical maintains a total of 95.77 Million outstanding shares. Nanjing Vishee Medical secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.99 % of Nanjing Vishee Medical outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nanjing Vishee Profitability Analysis
The company reported the revenue of 462.22 M. Net Income was 136.26 M with profit before overhead, payroll, taxes, and interest of 400.06 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nanjing Vishee's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nanjing Vishee and how it compares across the competition.
About Nanjing Vishee Valuation
The stock valuation mechanism determines Nanjing Vishee's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nanjing Vishee. We calculate exposure to Nanjing Vishee's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nanjing Vishee's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 381.5 M | 261 M |
Nanjing Vishee Quarterly Retained Earnings |
|
Complementary Tools for Nanjing Stock analysis
When running Nanjing Vishee's price analysis, check to measure Nanjing Vishee's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanjing Vishee is operating at the current time. Most of Nanjing Vishee's value examination focuses on studying past and present price action to predict the probability of Nanjing Vishee's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanjing Vishee's price. Additionally, you may evaluate how the addition of Nanjing Vishee to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |